GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Other Current Receivables

Apollomics (Apollomics) Other Current Receivables : $0.47 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Other Current Receivables?

Apollomics's Other Current Receivables for the quarter that ended in Dec. 2023 was $0.47 Mil.

Apollomics's quarterly Other Current Receivables declined from Dec. 2022 ($0.55 Mil) to Jun. 2023 ($0.51 Mil) but then stayed the same from Jun. 2023 ($0.51 Mil) to Dec. 2023 ($0.47 Mil).

Apollomics's annual Other Current Receivables increased from Dec. 2021 ($0.51 Mil) to Dec. 2022 ($0.55 Mil) but then declined from Dec. 2022 ($0.55 Mil) to Dec. 2023 ($0.47 Mil).

Apollomics Other Current Receivables Historical Data

The historical data trend for Apollomics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Other Current Receivables Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Receivables
0.42 0.51 0.55 0.47

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Receivables Get a 7-Day Free Trial 0.51 0.12 0.55 0.51 0.47

Apollomics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Apollomics Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Apollomics's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollomics (Apollomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Other Current Receivables
Comparable Companies
ATHA STTK ACXP CARA TLSA ORMP IMMX CCCC GTHX GBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
APLM:USA
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Website
https://www.apollomicsinc.com
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.